A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
Christoph StraubeKerstin A KesselStefanie AntoniJens GemptBernhard MeyerJuergen SchlegelFriederike Schmidt-GrafStephanie E CombsPublished in: Radiation oncology (London, England) (2020)
The score distinguishes patients with a poor prognosis from patients with a better prognosis. Its inclusion in future retrospective or prospective trials could help enhance the comparability of results. Before its employment on a routine basis, external validation is recommended.